Quarterly report pursuant to Section 13 or 15(d)

Revisions of Previously Issued Financial Statements (Details)

v3.20.2
Revisions of Previously Issued Financial Statements (Details) - USD ($)
3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2020
Mar. 31, 2020
Dec. 31, 2019
Sep. 30, 2019
Dec. 31, 2019
Mar. 31, 2020
Jun. 30, 2020
Total assets $ 81,334,782           $ 58,529,619
Total liabilities 23,613,226           21,955,213
Total stockholders' equity 57,721,556           $ 31,870,154
Cost of revenue   $ 1,396,219 $ 1,615,239 $ 1,379,701 $ 2,994,940 $ 4,391,159  
Gross profit   1,674,327 1,690,964 1,813,189 3,504,153 5,178,480  
Product development 1,758,826 874,787 623,501 610,902 1,234,403 2,109,190  
Selling, general and administrative   5,678,242 4,883,172 3,601,714 8,484,886 14,163,128  
Operating expenses $ 7,497,537     4,212,616      
Net loss   $ (4,744,129) $ (3,763,695) $ (2,326,332) $ (6,090,027) $ (10,834,156)  
Net loss per share $ (0.34) $ (0.38) $ (0.34) $ (0.21) $ (0.56) $ (0.96)  
As Reported [Member]              
Cost of revenue   $ 1,420,909 $ 1,638,840 $ 1,397,361 $ 3,036,201 $ 4,457,110  
Gross profit   1,649,637 1,667,363 1,795,529 3,462,892 5,112,529  
Product development   1,632,353 1,261,509 1,130,880 2,392,389 4,024,742  
Selling, general and administrative   5,500,837 4,796,404 3,583,815 8,380,219 13,881,056  
Net loss   $ (5,348,980) $ (4,338,536) $ (2,846,071) $ (7,184,607) $ (12,533,587)  
Net loss per share   $ (0.43) $ (0.40) $ (0.26) $ (0.66) $ (1.11)  
Adjustment [Member]              
Cost of revenue   $ (24,690) $ (23,601) $ (17,660) $ (41,261) $ (65,951)  
Gross profit   24,690 23,601 17,660 41,261 65,951  
Product development   (757,566) (638,008) (519,978) (1,157,986) (1,915,552)  
Selling, general and administrative   177,405 86,768 17,899 104,667 282,072  
Net loss   $ 604,851 $ 574,841 $ 519,739 $ 1,094,580 $ 1,699,431  
Net loss per share